WELCOME

*Please note ASRM guidelines were updated on 04.27.2020. Click the ASRM link below for more information.

C.A.R.E. for the Bay Area is committed to keeping our patients and staff healthy and safe. We are closely monitoring the Coronavirus (COVID-19) situation and are following the evolving guidelines put forth by local and national government agencies, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and the American Society for Reproductive Medicine (ASRM). 

As of 04.27.2020, ASRM has stated that clinics may resume care but will need to be flexible and fully prepared to recognize and address the status of their local Coronavirus transmission rate, medical conditions, and the impact that resuming operations would have on their community’s risk and resources, even when clinical activities are permitted by law.

To decrease transmission risk and exposure, C.A.R.E. will be implementing new practices and requirements for visits and for continued treatment. Compliance with these new practices is required when obtaining treatment.   Anyone, whether patient or staff, who is considered to be infectious will not be allowed to enter the clinic until they meet criteria for ending isolation after known or suspected infection. 

We appreciate your cooperation in keeping our patients and staff safe. If you have any non-urgent questions or concerns regarding COVID-19 or your fertility treatment, we highly encourage you to send us a message through your Patient Portal. Our staff will be monitoring the messages diligently and will respond to you as quickly as possible. For urgent matters, please call our office at 408-628-0783. For medical emergencies, please call 911.

For more information regarding COVID-19, please see 

https://www.cdc.gov/coronavirus/2019-ncov/index.html

For ASRM recommendations for fertility treatment, please see  https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/covid-19/covidtaskforceupdate3.pdf   (UPDATED 04.27.2020) 

A Message for Patients from The Society for Assisted Reproductive Technology:

https://www.sart.org/patients/covid-19-alert-for-patients/?utm_source=Informz&utm_medium=email&utm_campaign=EmailBlast 

------------------------------------------------------------------------------------------------------

**Research opportunity to help get answers about pregnancy and COVID-19**

The ASPIRE (Assessing the Safety of Pregnancy in the Coronavirus Pandemic) study is spearheaded by Drs. Marcelle Cedars, Heather Huddleston and Eleni Jaswa at the University of California, San Francisco (UCSF). Due to the short timeline since appearance of SARS-CoV-2 and its associated illness COVID-19, no data is available to clarify whether there are risks associated with this new virus, particularly for exposures in early pregnancy. We are faced with an immediate need for high-quality data to characterize the risks of COVID-19 to pregnant women. Because of our role in tracking and monitoring very early pregnancies across the United States, SART member clinics are uniquely positioned to provide critically needed answers.

We are asking all patients achieving pregnancy via IVF, IUI, and spontaneously, from April 30, 2020 through December 31st, 2020 about this study. Patient enrollment in the study is self-directed and voluntary.  You can participate in the study by registering here:  https://redcap.ucsf.edu/surveys/?s=DTDY3METCT 

For more information, please visit  https://aspire.ucsf.edu/ .